Harbor Investment Advisory’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482K Sell
8,368
-50
-0.6% -$2.87K 0.03% 300
2026
Q1
$511K Sell
8,418
-904
-10% -$52.7K 0.04% 281
2025
Q4
$503K Buy
9,322
+224
+2% +$10.8K 0.04% 282
2025
Q3
$410K Sell
9,098
-2,421
-21% -$113K 0.03% 304
2025
Q2
$533K Sell
11,519
-832
-7% -$40.8K 0.05% 255
2025
Q1
$753K Sell
12,351
-750
-6% -$43.7K 0.07% 192
2024
Q4
$741K Sell
13,101
-2,064
-14% -$115K 0.07% 188
2024
Q3
$785K Sell
15,165
-6,740
-31% -$316K 0.08% 190
2024
Q2
$910K Sell
21,905
-419
-2% -$18.7K 0.09% 160
2024
Q1
$1.21M Buy
22,324
+4,100
+22% +$209K 0.13% 130
2023
Q4
$935K Sell
18,224
-7,280
-29% -$382K 0.11% 150
2023
Q3
$1.48M Sell
25,504
-2,067
-7% -$127K 0.19% 90
2023
Q2
$1.76M Sell
27,571
-1,684
-6% -$113K 0.25% 79
2023
Q1
$2.03M Buy
29,255
+247
+0.9% +$17.4K 0.3% 72
2022
Q4
$2.09M Sell
29,008
-463
-2% -$34.9K 0.33% 68
2022
Q3
$2.1M Buy
29,471
+318
+1% +$23.1K 0.35% 63
2022
Q2
$2.25M Sell
29,153
-1,374
-5% -$105K 0.36% 57
2022
Q1
$2.23M Buy
30,527
+66
+0.2% +$4.43K 0.3% 66
2021
Q4
$1.9M Buy
30,461
+348
+1% +$20.4K 0.24% 82
2021
Q3
$1.78M Sell
30,113
-4,909
-14% -$323K 0.24% 80
2021
Q2
$2.34M Sell
35,022
-2,254
-6% -$147K 0.32% 67
2021
Q1
$2.35M Buy
37,276
+5,574
+18% +$347K 0.35% 63
2020
Q4
$1.97M Buy
31,702
+3,116
+11% +$192K 0.31% 67
2020
Q3
$1.72M Buy
28,586
+588
+2% +$35.4K 0.33% 68
2020
Q2
$1.65M Buy
27,998
+6,072
+28% +$363K 0.35% 63
2020
Q1
$1.22M Buy
21,926
+988
+5% +$60.4K 0.33% 68
2019
Q4
$1.34M Buy
+20,938
New +$1.2M 0.31% 73

Other funds holding BMY

Harbor Investment Advisory's BMY Position: Q2 2026 in Review

Harbor Investment Advisory reduced its Bristol-Myers Squibb (BMY) stake by 0.59% in Q2 2026, selling an estimated $2.87K and leaving 8,368 shares worth $482K. The position accounts for 0.03% of the portfolio, ranked #300.

Harbor Investment Advisory first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.35M in Q1 2021. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Harbor Investment Advisory held 8,368 shares of Bristol-Myers Squibb worth $482K as of Q2 2026.
  • Harbor Investment Advisory sold 50 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.87K.
  • Bristol-Myers Squibb made up 0.03% of Harbor Investment Advisory's portfolio in Q2 2026, its #300 holding.
  • Harbor Investment Advisory first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
  • Harbor Investment Advisory's Bristol-Myers Squibb position peaked at $2.35M in Q1 2021.
  • 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.